Double-blind Randomized Placebo-controlled Clinical Trial of Efficiency of Nonsteroidal Anti-inflammatory Drugs in the Control of Post-endodontic Pain

2016 ◽  
Vol 42 (6) ◽  
pp. 835-842 ◽  
Author(s):  
Wail M. Elzaki ◽  
Neamat H. Abubakr ◽  
Hassan M. Ziada ◽  
Yahia E. Ibrahim
Keyword(s):  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial

2021 ◽  
Author(s):  
Hellen Christina Neves Rodrigues ◽  
Tatiane Fagundes Pereira Martins ◽  
Nayara Cristina Freitas e Silva Santana ◽  
Clarice Carneiro Braga ◽  
Marina Alves Coelho Silva ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Inflammatory Response ◽  
Hemodialysis Patients ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Anti Inflammatory

Lame broiler chickens respond to non-steroidal anti-inflammatory drugs with objective changes in gait function: A controlled clinical trial

2013 ◽  
Vol 196 (3) ◽  
pp. 477-482 ◽  
Author(s):  
G. Caplen ◽  
G.R. Colborne ◽  
B. Hothersall ◽  
C.J. Nicol ◽  
A.E. Waterman-Pearson ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Broiler Chickens ◽  
Controlled Clinical Trial ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
Gait Function

Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial

2018 ◽  
Vol 32 (6) ◽  
pp. 1073-1079 ◽  
Author(s):  
Fatemeh Homayouni ◽  
Fatemeh Haidari ◽  
Mehdi Hedayati ◽  
Mehrnoosh Zakerkish ◽  
Kambiz Ahmadi
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Blood Pressure Lowering ◽  
Double Blind ◽  
Pressure Lowering ◽  
Anti Inflammatory

Acetaminophen or Nonsteroidal Anti-Inflammatory Drugs in Acute Musculoskeletal Trauma: A Multicenter, Double-Blind, Randomized, Clinical Trial

2018 ◽  
Vol 71 (3) ◽  
pp. 357-368.e8 ◽  
Author(s):  
Milan L. Ridderikhof ◽  
Philipp Lirk ◽  
Helma Goddijn ◽  
Edwin Vandewalle ◽  
Erik Schinkel ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Double Blind ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
Musculoskeletal Trauma

A Controlled Clinical Trial of a New Anti-Inflammatory Drug, Diftalone, in Rheumatoid Arthritis

1974 ◽  
Vol 2 (5) ◽  
pp. 338-346 ◽  
Author(s):  
Valentin Stroescu ◽  
Carmen Georgescu ◽  
Radu Voiosu
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Randomized Trial ◽  
Term Treatment ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Inflammatory Drug ◽  
Long Term Treatment ◽  
Anti Inflammatory

In a double-blind, randomized trial on thirty-two patients affected by classical or definite rheumatoid arthritis, we have tried the effectiveness and safety of 500 mg/day oral diftalone versus 75 mg/day oral indomethacin for a period of six to twelve months treatment. Diftalone proved to be an effective and well tolerated anti-inflammatory drug in long-term treatment of rheumatoid arthritis. Its activity and safety is at least comparable to that achieved by the use of indomethacin.

scholarly journals Anti-inflammatory effects of different statins in rheumatoid arthritis; a randomized double-blind controlled clinical trial

2019 ◽  
Vol 5 (1) ◽  
pp. e09-e09 ◽  
Author(s):  
Mansoor Karimifar ◽  
Mansour Salesi ◽  
Rasoul Ghasemian ◽  
Mozhgan Karimifar ◽  
Ziba Farajzadegan ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Anti Inflammatory

Kinetics of Analgesic Response in Man; an Example with Two Non-Steroidal Anti-Inflammatory Analgesic Drugs

1978 ◽  
Vol 6 (4) ◽  
pp. 312-316 ◽  
Author(s):  
G Sacchetti ◽  
G C Ferrati ◽  
L Parrinello ◽  
A Salami
Keyword(s):  
Half Life ◽  
Fixed Time ◽  
Controlled Clinical Trial ◽  
Time Intervals ◽  
Double Blind ◽  
Post Operative Pain ◽  
Inflammatory Drugs ◽  
Anti Inflammatory ◽  
Kinetics Of ◽  
Plasma Half Life

A double-blind, controlled clinical trial is described in which a total of forty hospital in-patients suffering from severe post-operative pain were randomly allocated to treatment with one of two non-steroidal anti-inflammatory drugs, namely, either indoprofen which has a short half-life (two hours) or naproxen which has a long half-life (thirteen hours). The drugs were administered orally on a single-dose-only basis. The doses used in this way were 300 mg of indoprofen or 250 mg of naproxen. Patients scored the severity of their pain on a five-point scale and these scores were recorded prior to and at fixed time intervals up to eight hours following administration of medication. No significant differences emerged between the two test drugs and the duration of the response was also found to be similar for the two compounds despite their very different plasma half-life values.

Sign in / Sign up

Export Citation Format

Share Document